Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Immunogenicity and Efficacy of Subunit Vaccine Against Herpes Zoster in RA Treated With JAK-inhibitors (VACCIMIL-ZOSTER)

NCT03886038 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT03886038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03886038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Immunogenicity and Efficacy of Subunit Vaccine Against Herpes Zoster in RA Treated With JAK-inhibitors (VACCIMIL-ZOSTER)
Lead sponsor
Region Skane
Phase
Phase 4
Overall status
Completed
Start date
March 15, 2019
Completion date
February 15, 2022
Enrollment
142 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy controls, rheumatoid arthritis